Protalix BioTherapeutics, Inc. Revenue
Protalix BioTherapeutics, Inc. (PLX) reported Revenue of $19.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-12
- Protalix BioTherapeutics, Inc. revenues for the quarter ending 2026-06-30 was $19.90M, a 27.07% increase year-over-year.
- Protalix BioTherapeutics, Inc. revenues for the quarter ending 2026-03-31 was $33.75M, a 233.73% increase year-over-year.
- Protalix BioTherapeutics, Inc. revenues for the quarter ending 2025-12-31 was $9.12M, a 49.93% decline year-over-year.
- Protalix BioTherapeutics, Inc. revenues for the quarter ending 2025-09-30 was $17.85M, a 0.60% decline year-over-year.
- Protalix BioTherapeutics, Inc. revenues for fiscal 2025 was $52.74M, a 1.23% decline from fiscal 2024.
- Protalix BioTherapeutics, Inc. revenues for fiscal 2024 was $53.40M, a 18.47% decline from fiscal 2023.
- Protalix BioTherapeutics, Inc. revenues for fiscal 2023 was $65.49M, a 37.48% increase from fiscal 2022.
- Protalix BioTherapeutics, Inc. revenues for fiscal 2022 was $47.64M, a 24.22% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 12 month | Revenues 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $19.90M 10-Q · filed 2026-08-12 | $53.65M 10-Q · filed 2026-08-12 | $62.77M derived: sum of 3 quarters · filed 2026-08-12 | $80.62M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2026-03-31 | $33.75M 10-Q · filed 2026-05-13 | $42.87M derived: sum of 2 quarters · filed 2026-05-13 | $60.72M derived: sum of 3 quarters · filed 2026-05-13 | $76.38M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-12-31 | $9.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $26.97M derived: sum of 2 quarters · filed 2026-03-18 | $42.63M derived: sum of 3 quarters · filed 2026-08-12 | $52.74M 10-K · filed 2026-03-18 | |||
| 2025-09-30 | $17.85M 10-Q · filed 2025-11-13 | $33.51M derived: sum of 2 quarters · filed 2026-08-12 | $43.62M 10-Q · filed 2025-11-13 | $61.84M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-06-30 | $15.66M 10-Q · filed 2026-08-12 | $25.77M 10-Q · filed 2026-08-12 | $43.99M derived: sum of 3 quarters · filed 2026-08-12 | $61.95M derived: sum of 4 quarters · filed 2026-08-12 | |||
| 2025-03-31 | $10.11M 10-Q · filed 2026-05-13 | $28.33M derived: sum of 2 quarters · filed 2026-05-13 | $46.29M derived: sum of 3 quarters · filed 2026-05-13 | $59.76M derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $18.22M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $36.18M derived: sum of 2 quarters · filed 2026-03-18 | $49.65M derived: sum of 3 quarters · filed 2026-03-18 | $53.40M 10-K · filed 2026-03-18 | |||
| 2024-09-30 | $17.96M 10-Q · filed 2025-11-13 | $31.43M derived: sum of 2 quarters · filed 2025-11-13 | $35.18M 10-Q · filed 2025-11-13 | $45.67M derived: sum of 4 quarters · filed 2026-03-18 | |||
| 2024-06-30 | $13.47M 10-Q · filed 2025-08-14 | $17.22M 10-Q · filed 2025-08-14 | $27.71M derived: sum of 3 quarters · filed 2026-03-18 | $38.05M derived: sum of 4 quarters · filed 2026-03-18 | |||
| 2024-03-31 | $3.75M 10-Q · filed 2025-05-09 | $14.23M derived: sum of 2 quarters · filed 2026-03-18 | $24.58M derived: sum of 3 quarters · filed 2026-03-18 | $59.65M derived: sum of 4 quarters · filed 2026-03-18 | |||
| 2023-12-31 | $10.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $20.83M derived: sum of 2 quarters · filed 2026-03-18 | $55.91M derived: sum of 3 quarters · filed 2026-03-18 | $65.49M 10-K · filed 2026-03-18 | |||
| 2023-09-30 | $10.35M 10-Q · filed 2024-11-14 | $45.42M derived: sum of 2 quarters · filed 2024-11-14 | $55.01M 10-Q · filed 2024-11-14 | $63.63M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-06-30 | $35.08M 10-Q · filed 2024-08-14 | $44.66M 10-Q · filed 2024-08-14 | $53.28M derived: sum of 3 quarters · filed 2025-03-17 | $67.46M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2023-03-31 | $9.59M 10-Q · filed 2024-05-10 | $18.20M derived: sum of 2 quarters · filed 2025-03-17 | $32.39M derived: sum of 3 quarters · filed 2025-03-17 | $41.14M derived: sum of 4 quarters · filed 2025-03-17 | |||
| 2022-12-31 | $8.62M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $22.80M derived: sum of 2 quarters · filed 2025-03-17 | $31.55M derived: sum of 3 quarters · filed 2025-03-17 | $47.64M 10-K · filed 2025-03-17 | |||
| 2022-09-30 | $14.18M 10-Q · filed 2023-11-06 | $22.94M derived: sum of 2 quarters · filed 2023-11-06 | $39.02M 10-Q · filed 2023-11-06 | $47.57M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-06-30 | $8.75M 10-Q · filed 2023-08-07 | $24.84M 10-Q · filed 2023-08-07 | $33.39M derived: sum of 3 quarters · filed 2024-03-14 | $45.44M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2022-03-31 | $16.09M 10-Q · filed 2023-05-04 | $24.63M derived: sum of 2 quarters · filed 2024-03-14 | $36.69M derived: sum of 3 quarters · filed 2024-03-14 | $43.12M derived: sum of 4 quarters · filed 2024-03-14 | |||
| 2021-12-31 | $8.55M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $20.60M derived: sum of 2 quarters · filed 2024-03-14 | $27.03M derived: sum of 3 quarters · filed 2024-03-14 | $38.35M 10-K · filed 2024-03-14 | |||
| 2021-09-30 | $12.05M 10-Q · filed 2022-11-14 | $18.48M derived: sum of 2 quarters · filed 2022-11-14 | $29.80M 10-Q · filed 2022-11-14 | $49.30M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-06-30 | $6.43M 10-Q · filed 2022-08-15 | $17.75M 10-Q · filed 2022-08-15 | $37.24M derived: sum of 3 quarters · filed 2023-02-27 | $48.03M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2021-03-31 | $11.32M 10-Q · filed 2022-05-16 | $30.82M derived: sum of 2 quarters · filed 2023-02-27 | $41.60M derived: sum of 3 quarters · filed 2023-02-27 | $52.57M derived: sum of 4 quarters · filed 2023-02-27 | |||
| 2020-12-31 | $19.50M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $30.29M derived: sum of 2 quarters · filed 2023-02-27 | $41.25M derived: sum of 3 quarters · filed 2023-02-27 | $62.90M 10-K · filed 2023-02-27 | |||
| 2020-09-30 | $10.79M 10-Q · filed 2021-11-15 | $21.76M derived: sum of 2 quarters · filed 2021-11-15 | $43.40M 10-Q · filed 2021-11-15 | $61.16M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2020-06-30 | $10.97M 10-Q · filed 2021-08-16 | $32.61M 10-Q · filed 2021-08-16 | $50.37M derived: sum of 3 quarters · filed 2022-03-31 | $64.62M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2020-03-31 | $21.65M 10-Q · filed 2021-05-14 | $39.41M derived: sum of 2 quarters · filed 2022-03-31 | $53.65M derived: sum of 3 quarters · filed 2022-03-31 | $65.90M derived: sum of 4 quarters · filed 2022-03-31 | |||
| 2019-12-31 | $17.76M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $32.01M derived: sum of 2 quarters · filed 2022-03-31 | $44.25M derived: sum of 3 quarters · filed 2022-03-31 | $54.69M 10-K · filed 2022-03-31 | |||
| 2019-09-30 | $14.25M 10-Q · filed 2020-10-29 | $26.50M derived: sum of 2 quarters · filed 2020-10-29 | $36.93M 10-Q · filed 2020-10-29 | $63.95M derived: sum of 4 quarters · filed 2021-03-30 | |||
| 2019-06-30 | $12.25M 10-Q · filed 2020-08-10 | $22.69M 10-Q · filed 2020-08-10 | $49.70M derived: sum of 3 quarters · filed 2021-03-30 | $50.37M derived: sum of 4 quarters · filed 2021-03-30 | |||
| 2019-03-31 | $10.44M 10-Q · filed 2020-06-01 | $37.46M derived: sum of 2 quarters · filed 2021-03-30 | $38.12M derived: sum of 3 quarters · filed 2021-03-30 | $40.13M derived: sum of 4 quarters · filed 2021-03-30 | |||
| 2018-12-31 | $27.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $27.68M derived: sum of 2 quarters · filed 2021-03-30 | $29.69M derived: sum of 3 quarters · filed 2021-03-30 | $34.24M 10-K · filed 2021-03-30 | |||
| 2018-09-30 | $663.00K 10-Q · filed 2018-11-07 | $2.67M derived: sum of 2 quarters · filed 2018-11-07 | $7.22M 10-Q · filed 2018-11-07 | $11.53M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-06-30 | $2.01M 10-Q · filed 2018-08-09 | $6.56M 10-Q · filed 2018-08-09 | $10.86M derived: sum of 3 quarters · filed 2020-03-12 | $18.39M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2018-03-31 | $4.55M 10-Q · filed 2018-05-09 | $8.86M derived: sum of 2 quarters · filed 2020-03-12 | $16.38M derived: sum of 3 quarters · filed 2020-03-12 | $22.74M derived: sum of 4 quarters · filed 2020-03-12 | |||
| 2017-12-31 | $4.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-12 | $11.83M derived: sum of 2 quarters · filed 2020-03-12 | $18.19M derived: sum of 3 quarters · filed 2020-03-12 | $21.08M 10-K · filed 2020-03-12 | $19.24M 10-K · filed 2018-03-06 | ||
| 2017-09-30 | $7.53M 10-Q · filed 2018-11-07 | $13.88M derived: sum of 2 quarters · filed 2018-11-07 | $16.77M 10-Q · filed 2018-11-07 | $18.85M derived: sum of 4 quarters · filed 2018-11-07 | |||
| 2017-06-30 | $6.36M 10-Q · filed 2018-08-09 | $9.25M 10-Q · filed 2018-08-09 | $11.33M derived: sum of 3 quarters · filed 2018-08-09 | $16.00M derived: sum of 4 quarters · filed 2018-08-09 | |||
| 2017-03-31 | $2.89M 10-Q · filed 2018-05-09 | $4.97M derived: sum of 2 quarters · filed 2018-05-09 | $9.64M derived: sum of 3 quarters · filed 2018-05-09 | $11.41M derived: sum of 4 quarters · filed 2018-05-09 | |||
| 2016-12-31 | $2.08M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $6.75M derived: sum of 2 quarters · filed 2018-03-06 | $8.52M derived: sum of 3 quarters · filed 2018-03-06 | $9.20M 10-K · filed 2018-03-06 | |||
| 2016-09-30 | $4.67M 10-Q · filed 2017-11-08 | $6.44M derived: sum of 2 quarters · filed 2017-11-08 | $7.12M 10-Q · filed 2017-11-08 | $7.12M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-06-30 | $1.77M 10-Q · filed 2017-08-09 | $2.45M 10-Q · filed 2017-08-09 | $2.45M derived: sum of 3 quarters · filed 2018-03-06 | $3.78M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2016-03-31 | $679.00K 10-Q · filed 2017-05-10 | $679.00K derived: sum of 2 quarters · filed 2018-03-06 | $2.02M derived: sum of 3 quarters · filed 2018-03-06 | $3.35M derived: sum of 4 quarters · filed 2018-03-06 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $1.34M derived: sum of 2 quarters · filed 2018-03-06 | $2.67M derived: sum of 3 quarters · filed 2018-03-06 | $4.36M 10-K · filed 2018-03-06 | |||
| 2015-09-30 | $1.34M 10-Q · filed 2016-11-09 | $2.67M derived: sum of 2 quarters · filed 2016-11-09 | $4.36M 10-Q · filed 2016-11-09 | -$3.63M derived: sum of 4 quarters · filed 2017-03-16 | |||
| 2015-06-30 | $1.34M 10-Q · filed 2016-08-08 | $3.78M 10-Q · filed 2015-08-10 | $3.03M 10-Q · filed 2016-08-08 | $8.17M 10-Q · filed 2015-08-10 | -$4.97M derived: sum of 3 quarters · filed 2017-03-16 | -$2.57M derived: sum of 4 quarters · filed 2017-03-16 | |
| 2015-03-31 | $1.69M 10-Q · filed 2016-05-09 | $4.39M 10-Q · filed 2015-05-07 | -$6.30M derived: sum of 2 quarters · filed 2017-03-16 | -$3.91M derived: sum of 3 quarters · filed 2017-03-16 | -$1.48M derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-12-31 | -$7.99M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | -$5.60M derived: sum of 2 quarters · filed 2017-03-16 | -$3.17M derived: sum of 3 quarters · filed 2017-03-16 | $3.52M 10-K · filed 2017-03-16 | $13.65M 10-K · filed 2015-03-12 | ||
| 2014-09-30 | $2.40M 10-Q · filed 2014-11-10 | $4.82M derived: sum of 2 quarters · filed 2015-08-10 | $11.52M 10-Q · filed 2014-11-10 | $3.40M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-06-30 | $2.42M 10-Q · filed 2015-08-10 | $9.12M 10-Q · filed 2015-08-10 | $1.00M derived: sum of 3 quarters · filed 2016-03-08 | $3.29M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2014-03-31 | $6.70M 10-Q · filed 2015-05-07 | -$1.42M derived: sum of 2 quarters · filed 2016-03-08 | $864.00K derived: sum of 3 quarters · filed 2016-03-08 | $3.13M derived: sum of 4 quarters · filed 2016-03-08 | |||
| 2013-12-31 | -$8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08 | -$5.83M derived: sum of 2 quarters · filed 2016-03-08 | -$3.57M derived: sum of 3 quarters · filed 2016-03-08 | $0.00 10-K · filed 2016-03-08 | $10.48M 10-K · filed 2014-03-13 | ||
| 2013-09-30 | $2.28M 10-Q · filed 2014-11-10 | $4.55M derived: sum of 2 quarters · filed 2014-11-10 | $8.12M 10-Q · filed 2014-11-10 | $9.29M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-06-30 | $2.26M 10-Q · filed 2014-08-07 | $5.83M 10-Q · filed 2014-08-07 | $7.00M derived: sum of 3 quarters · filed 2015-03-12 | $10.73M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2013-03-31 | $3.57M 10-Q · filed 2014-05-08 | $4.74M derived: sum of 2 quarters · filed 2015-03-12 | $8.46M derived: sum of 3 quarters · filed 2015-03-12 | $34.58M derived: sum of 4 quarters · filed 2015-03-12 | |||
| 2012-12-31 | $1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $4.90M derived: sum of 2 quarters · filed 2015-03-12 | $31.01M derived: sum of 3 quarters · filed 2015-03-12 | $34.87M 10-K · filed 2015-03-12 | |||
| 2012-09-30 | $3.72M 10-Q · filed 2013-11-07 | $29.84M derived: sum of 2 quarters · filed 2013-11-07 | $33.70M 10-Q · filed 2013-11-07 | $36.06M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-06-30 | $26.11M 10-Q · filed 2013-08-08 | $29.97M 10-Q · filed 2013-08-08 | $32.34M derived: sum of 3 quarters · filed 2014-03-13 | $33.47M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2012-03-31 | $3.86M 10-Q · filed 2013-05-09 | $6.22M derived: sum of 2 quarters · filed 2014-03-13 | $7.36M derived: sum of 3 quarters · filed 2014-03-13 | $8.12M derived: sum of 4 quarters · filed 2014-03-13 | |||
| 2011-12-31 | $2.36M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $3.49M derived: sum of 2 quarters · filed 2014-03-13 | $4.26M derived: sum of 3 quarters · filed 2014-03-13 | $8.39M 10-K · filed 2014-03-13 | |||
| 2011-09-30 | $1.13M 10-Q · filed 2012-11-07 | $1.90M derived: sum of 2 quarters · filed 2012-11-07 | $6.02M 10-Q · filed 2012-11-07 | $7.20M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-06-30 | $764.00K 10-Q · filed 2012-08-03 | $4.89M 10-Q · filed 2012-08-03 | $6.07M derived: sum of 3 quarters · filed 2013-02-28 | $9.25M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-03-31 | $4.13M 10-Q · filed 2012-05-09 | $5.30M derived: sum of 2 quarters · filed 2013-02-28 | $8.49M derived: sum of 3 quarters · filed 2013-02-28 | $9.63M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2010-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | $4.36M derived: sum of 2 quarters · filed 2013-02-28 | $5.50M derived: sum of 3 quarters · filed 2013-02-28 | $6.64M 10-K · filed 2013-02-28 | |||
| 2010-09-30 | $3.18M 10-Q · filed 2011-11-07 | $4.33M derived: sum of 2 quarters · filed 2011-11-07 | $5.47M 10-Q · filed 2011-11-07 | ||||
| 2010-06-30 | $1.14M 10-Q · filed 2011-08-08 | $2.28M 10-Q · filed 2011-08-08 | |||||
| 2009-12-31 | $388.00K 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |